This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Chongqing Pharmaceutical Research Institute Co., Ltd, Yaopharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Peiyu Xie: Innovator in Pharmaceutical Chemistry
Introduction
Peiyu Xie is a notable inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on fluvatinib.
Latest Patents
Peiyu Xie holds 1 patent for his invention titled "Crystalline form of fluvatinib or fluvatinib methanesulfonate and preparation method therefor." This patent discloses a crystalline form of fluvatinib or fluvatinib methanesulfonate, along with a preparation method. The crystalline form I of fluvatinib exhibits characteristic diffraction peaks, which are essential for its identification. Additionally, the crystalline form of fluvatinib methanesulfonate can exist in multiple forms, including seven distinct crystalline forms, labeled I-VII. Notably, crystalline form III has its own unique diffraction peaks, making it suitable for manufacturing processes related to fluvatinib methanesulfonate formulations.
Career Highlights
Throughout his career, Peiyu Xie has worked with prominent organizations, including Chongqing Pharmaceutical Research Institute Co., Ltd. and Yaopharma Co., Ltd. His experience in these companies has allowed him to develop and refine his expertise in pharmaceutical research and development.
Collaborations
Peiyu Xie has collaborated with several professionals in his field, including Shuai He and Yang Zhang. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Peiyu Xie's contributions to pharmaceutical chemistry, particularly through his patent on fluvatinib, highlight his innovative spirit and dedication to advancing medical science. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile